NewsBenzinga오큐젠, 바하마 규제 당국으로부터 OCU400 임시 승인 및 우선 심사 지정 획득···EAP를 통해 OCU400 공급 예정, 90일 이내 첫 RP 환자 치료 목표 오큐젠, 바하마 규제 당국으로부터 OCU400 임시 승인 및 우선 심사 지정 획득···EAP를 통해 OCU400 공급 예정, 90일 이내 첫 RP 환자 치료 목표 Benzinga 2026.09.25 11:13 (GMT+0) Open on Benzinga Other news Intel Shares Fall 3.3% Pre-Market After Nvidia Cuts Its Stake in the Company by 25% Bitcoin, Ether Lose Over 13% in Week as Rebound Fades NRX Pharmaceuticals Q3 EPS $(0.05) Beats $(0.21) Estimate, Sales $1.159M Miss $1.300M Estimate HUYA Q3 Adj. EPS $0.03 Up From $0.02 YoY, Sales $261.441M Up From $237.147M YoY Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’ KOSPI Closes Below 5,000 as Chip Stocks Extend Slide
Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’